IL90047A - Cysteine-depleted biologically active muteins other than interferon - ' - Google Patents

Cysteine-depleted biologically active muteins other than interferon - '

Info

Publication number
IL90047A
IL90047A IL90047A IL9004783A IL90047A IL 90047 A IL90047 A IL 90047A IL 90047 A IL90047 A IL 90047A IL 9004783 A IL9004783 A IL 9004783A IL 90047 A IL90047 A IL 90047A
Authority
IL
Israel
Prior art keywords
interferon
depleted
cysteine
biologically active
active muteins
Prior art date
Application number
IL90047A
Other languages
English (en)
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Priority claimed from IL69970A external-priority patent/IL69970A/xx
Publication of IL90047A publication Critical patent/IL90047A/xx

Links

IL90047A 1982-10-19 1983-10-14 Cysteine-depleted biologically active muteins other than interferon - ' IL90047A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43515482A 1982-10-19 1982-10-19
IL69970A IL69970A (en) 1982-10-19 1983-10-14 Biologically active cysteine-depleted muteins of interferon-beta

Publications (1)

Publication Number Publication Date
IL90047A true IL90047A (en) 1992-12-01

Family

ID=23727220

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90047A IL90047A (en) 1982-10-19 1983-10-14 Cysteine-depleted biologically active muteins other than interferon - '

Country Status (4)

Country Link
JP (4) JPS5993093A (enExample)
IL (1) IL90047A (enExample)
IN (1) IN161992B (enExample)
ZA (1) ZA837789B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
WO1986002381A1 (en) * 1984-10-15 1986-04-24 Cetus Corporation Human tumor necrosis factor
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
JP2583753B2 (ja) * 1984-12-21 1997-02-19 大塚製薬株式会社 抗腫瘍活性物質およびその製造法
JP2721854B2 (ja) * 1984-12-21 1998-03-04 大塚製薬株式会社 抗腫瘍活性物質
IL78571A (en) * 1985-04-22 1991-06-30 Genentech Inc Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form
US4818698A (en) * 1985-08-23 1989-04-04 Toyo Jozo Co., Ltd. Polypeptides and preparation process thereof
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
DE69025211T2 (de) * 1989-02-17 1996-09-19 Merck & Co Inc Protein-Antikrebsmittel
NZ232900A (en) * 1989-03-22 1993-08-26 Merck & Co Inc Pseudomonas exotoxin a, pe 40 domain derivatives
US6207798B1 (en) 1989-08-03 2001-03-27 Merck & Co., Inc. Modified PE40 toxin fusion proteins
JPH0751621A (ja) * 1993-08-12 1995-02-28 Kansei Kogyo Kk 静電吸着による管内面更生工法
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
JP2007530419A (ja) * 2003-07-11 2007-11-01 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 改良組換えヒトインターフェロン−β−１ｂポリペプチド
CN116075523A (zh) * 2020-04-29 2023-05-05 基因制药株式会社 具有融合的干扰素-β突变蛋白和抗体的重组蛋白以及包含其的药物组合物

Also Published As

Publication number Publication date
JPH057996B2 (enExample) 1993-01-29
ZA837789B (en) 1984-11-28
JPH0380475B2 (enExample) 1991-12-25
JPS6128384A (ja) 1986-02-08
JPS6128393A (ja) 1986-02-08
JPS6128394A (ja) 1986-02-08
JPS6357440B2 (enExample) 1988-11-11
JPS5993093A (ja) 1984-05-29
IN161992B (enExample) 1988-03-12

Similar Documents

Publication Publication Date Title
EG16786A (en) Low-temperature effective composition and delivery systems therefor
DE3370378D1 (en) Biologically active composition and immunoassay using the same
DE3368057D1 (en) Pharmaceutically active aminobenzopyrans
IL90047A (en) Cysteine-depleted biologically active muteins other than interferon - '
ZA832549B (en) Pharmaceutically active compounds
HUT46539A (en) Biologically active copolimers
EP0103537A3 (en) N-arylsulfonyl-n'-triazolyl urea
GB2130220B (en) Pharmacologically active peptides
PL253413A1 (en) Biologicaly active agent
DE3264659D1 (en) Biologically active peptides
GB8430255D0 (en) Biologically active oligopeptides
GB2166139B (en) Biologically active penta-and heptapeptides
DE3372284D1 (en) N,n-dialkyl-2-(4'-substituted-1'-naphthoxy)propionamides
IL90047A0 (en) Cysteine-depleted muteins of biologically active proteins
GB8512761D0 (en) Biologically active tridecapeptides
GR861651B (en) Biologically active copolymers
ZA879256B (en) Biologically active agent
GB8328940D0 (en) Biologically active nitrogen compounds
GB8328939D0 (en) Biologically active nitrogen compounds
PL238333A2 (en) "ela" puzzle
GB8315519D0 (en) Biologically active mixture
GB8315521D0 (en) Biologically active mixture
GB8423771D0 (en) Biologically active peptides
RO83236B1 (ro) Pansament oftalmologic biologic activ
IE811320L (en) Biologically active peptides

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired